메뉴 건너뛰기




Volumn 39, Issue 8, 2012, Pages 1583-1602

Canadian rheumatology association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: Part II safety

(18)  Bombardier, Claire a,b,c,d   Hazlewood, Glen S e   Akhavan, Pooneh e   Schieir, Orit e   Dooley, Anne e   Haraoui, Boulos e   Khraishi, Majed f,g   Leclercq, Sharon A h   Légaré, Jean h   Mosher, Dianne P h   Pencharz, James i   Pope, Janet E i   Thomson, John k   Thorne, Carter j   Zummer, Michel l   Gardam, Michael A m   Askling, Johan n   Bykerk, Vivian a,b,c  


Author keywords

Consensus development conference; Postmarketing product surveillance; Practice guidelines; Quality of healthcare; Rheumatoid arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; BCG VACCINE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLIMUMAB; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INACTIVATED VACCINE; INFLIXIMAB; INFLUENZA VACCINE; ISONIAZID; LEFLUNOMIDE; LIVE VACCINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; RIFAMPICIN; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

EID: 84864542624     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120165     Document Type: Article
Times cited : (117)

References (115)
  • 1
    • 84864570470 scopus 로고    scopus 로고
    • Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
    • Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.
    • (2012) J Rheumatol , vol.39 , pp. 1559-1582
    • Bykerk, V.P.1    Akhavan, P.2    Hazlewood, G.S.3    Schieir, O.4    Dooley, A.5    Haraoui, B.6
  • 2
    • 84864546733 scopus 로고    scopus 로고
    • Emerging issues in pharmacological management of rheumatoid arthritis: Results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations
    • Bykerk VP, Schieir O, Akhavan P, Hazlewood GS, Cheng CK, Bombardier C. Emerging issues in pharmacological management of rheumatoid arthritis: Results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations. J Rheumatol 2012;39:1555-8.
    • (2012) J Rheumatol , vol.39 , pp. 1555-1558
    • Bykerk, V.P.1    Schieir, O.2    Akhavan, P.3    Hazlewood, G.S.4    Cheng, C.K.5    Bombardier, C.6
  • 3
    • 77956055481 scopus 로고    scopus 로고
    • 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
    • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
    • (2010) Arthritis Rheum , vol.62 , pp. 2569-2581
    • Aletaha, D.1    Neogi, T.2    Silman, A.J.3    Funovits, J.4    Felson, D.T.5    Bingham III, C.O.6
  • 6
    • 84887542094 scopus 로고    scopus 로고
    • Ottawa: Canadian Agency for Drugs and Technology in Health; [Internet. Accessed April 5, 2012.] Available from
    • Canadian Agency for Drugs and Technology in Health. Grey matters: A practical search tool for evidence-based medicine. Ottawa: Canadian Agency for Drugs and Technology in Health; 2009. [Internet. Accessed April 5, 2012.] Available from: http://www.cadth.ca/en/resources/grey-matters
    • (2009) Grey Matters: A Practical Search Tool for Evidence-based Medicine
  • 7
    • 0037323867 scopus 로고    scopus 로고
    • Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project
    • AGREE Collaboration
    • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 2003;12:18-23.
    • (2003) Qual Saf Health Care , vol.12 , pp. 18-23
  • 8
    • 0003562478 scopus 로고    scopus 로고
    • Edinburgh: Scottish Intercollegiate Guidelines Network; [Internet. Accessed March 30, 2012.] Available from
    • Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: A guideline developer's handbook. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008. [Internet. Accessed March 30, 2012.] Available from: http://www.sign.ac. uk/guidelines/fulltext/50/index.html
    • (2008) SIGN 50: A Guideline Developer's Handbook
  • 9
    • 24044445860 scopus 로고    scopus 로고
    • The guideline implementability appraisal (GLIA): Development of an instrument to identify obstacles to guideline implementation
    • Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The guideline implementability appraisal (GLIA): Development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak 2005;5:23.
    • (2005) BMC Med Inform Decis Mak , vol.5 , pp. 23
    • Shiffman, R.N.1    Dixon, J.2    Brandt, C.3    Essaihi, A.4    Hsiao, A.5    Michel, G.6
  • 11
    • 34047163955 scopus 로고    scopus 로고
    • Patients with Rheumatoid Arthritis Undergoing Surgery: How Should We Deal with Antirheumatic Treatment?
    • DOI 10.1016/j.semarthrit.2006.10.003, PII S0049017206001612
    • Pieringer H, Stuby U, Biesenbach G. Patients with rheumatoid arthritis undergoing surgery: How should we deal with antirheumatic treatment? Semin Arthritis Rheum 2007;36:278-86. (Pubitemid 46517632)
    • (2007) Seminars in Arthritis and Rheumatism , vol.36 , Issue.5 , pp. 278-286
    • Pieringer, H.1    Stuby, U.2    Biesenbach, G.3
  • 12
    • 84655169655 scopus 로고    scopus 로고
    • Perioperative care for patients with rheumatic diseases
    • Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol 2011;8:32-41.
    • (2011) Nat Rev Rheumatol , vol.8 , pp. 32-41
    • Akkara Veetil, B.M.1    Bongartz, T.2
  • 13
    • 45849124232 scopus 로고    scopus 로고
    • BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
    • [Internet. Accessed March 30, 2012.] Available from
    • Chakravarty K, McDonald H, Pullar T, Taggart A, Chalmers R, Oliver S, et al. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008;47:924-5. [Internet. Accessed March 30, 2012.] Available from: http://rheumatology.oxfordjournals.org/content/suppl/2008/05/31/kel216a.DC1/ kel216b.pdf
    • (2008) Rheumatology , vol.47 , pp. 924-925
    • Chakravarty, K.1    McDonald, H.2    Pullar, T.3    Taggart, A.4    Chalmers, R.5    Oliver, S.6
  • 14
    • 65549119170 scopus 로고    scopus 로고
    • British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)
    • Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.
    • (2009) Rheumatology , vol.48 , pp. 436-439
    • Luqmani, R.1    Hennell, S.2    Estrach, C.3    Basher, D.4    Birrell, F.5    Bosworth, A.6
  • 15
    • 67549096874 scopus 로고    scopus 로고
    • Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
    • Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086-93.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1086-1093
    • Visser, K.1    Katchamart, W.2    Loza, E.3    Martinez-Lopez, J.A.4    Salliot, C.5    Trudeau, J.6
  • 16
    • 84873066492 scopus 로고    scopus 로고
    • Madrid: Sociedad Espanola de Reumatologia; [Internet. Accessed March 30, 2012.] Available from
    • Spanish Society of Rheumatology. Update of the clinical practise guideline for the management of rheumatoid arthritis in Spain. Madrid: Sociedad Espanola de Reumatologia; 2007. [Internet. Accessed March 30, 2012.] Available from: http://www.ser.es/practicaClinica/Guias-Practica-Clinica.php
    • (2007) Update of the Clinical Practise Guideline for the Management of Rheumatoid Arthritis in Spain
  • 17
    • 0035089096 scopus 로고    scopus 로고
    • Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery
    • DOI 10.1136/ard.60.3.214
    • Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001;60:214-7. (Pubitemid 32260601)
    • (2001) Annals of the Rheumatic Diseases , vol.60 , Issue.3 , pp. 214-217
    • Grennan, D.M.1    Gray, J.2    Loudon, J.3    Fear, S.4
  • 19
    • 33644507068 scopus 로고    scopus 로고
    • Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery
    • Murata K, Yasuda T, Ito H, Yoshida M, Shimizu M, Nakamura T. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod Rheumatol 2006;16:14-9.
    • (2006) Mod Rheumatol , vol.16 , pp. 14-19
    • Murata, K.1    Yasuda, T.2    Ito, H.3    Yoshida, M.4    Shimizu, M.5    Nakamura, T.6
  • 20
    • 0025767122 scopus 로고
    • Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?
    • Bridges SL Jr, Lopez-Mendez A, Han KH, Tracy IC, Alarcon GS. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-8.
    • (1991) J Rheumatol , vol.18 , pp. 984-988
    • Bridges Jr., S.L.1    Lopez-Mendez, A.2    Han, K.H.3    Tracy, I.C.4    Alarcon, G.S.5
  • 21
    • 0029981838 scopus 로고    scopus 로고
    • Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy
    • Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 1996;19:207-10. (Pubitemid 26089384)
    • (1996) Orthopedics , vol.19 , Issue.3 , pp. 207-210
    • Carpenter, M.T.1    West, S.G.2    Vogelgesang, S.A.3    Jones, D.E.C.4
  • 22
    • 84873071535 scopus 로고    scopus 로고
    • Sydney: Australian Rheumatology Association; [Internet. Accessed April 2, 2012.] Available from
    • Australian Rheumatology Association. Updated recommendations for the use of biological agents for the treatment of rheumatic diseases. Sydney: Australian Rheumatology Association; 2010. [Internet. Accessed April 2, 2012.] Available from: http://www.rheumatology.org.au/downloads/FINAL-biological- recommendations060111.pdf
    • (2010) Updated Recommendations for the Use of Biological Agents for the Treatment of Rheumatic Diseases
  • 24
    • 68549105886 scopus 로고    scopus 로고
    • Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
    • Koike R, Harigai M, Atsumi T, Amano K, Kawai S, Saito K, et al. Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheumatol 2009;19:351-7.
    • (2009) Mod Rheumatol , vol.19 , pp. 351-357
    • Koike, R.1    Harigai, M.2    Atsumi, T.3    Amano, K.4    Kawai, S.5    Saito, K.6
  • 25
    • 14044260093 scopus 로고    scopus 로고
    • Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
    • DOI 10.1093/rheumatology/keh464
    • Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005;44:157-63. (Pubitemid 40277395)
    • (2005) Rheumatology , vol.44 , Issue.2 , pp. 157-163
    • Ledingham, J.1    Deighton, C.2
  • 26
    • 33745937104 scopus 로고    scopus 로고
    • Consensus on the use and monitoring of anti-TNF-alpha therapies for rheumatic diseases in Hong Kong 2005
    • DOI 10.1111/j.1479-8077.2006.00194.x
    • Mok CC. Consensus on the use and monitoring of anti-TNF-alpha therapies for rheumatic diseases in Hong Kong 2005. APLAR J Rheumatol 2006;9:175-80. (Pubitemid 44057336)
    • (2006) APLAR Journal of Rheumatology , vol.9 , Issue.2 , pp. 175-180
    • Mok, C.C.1
  • 32
    • 73349122592 scopus 로고    scopus 로고
    • Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis
    • Spanish Society of Rheumatology.
    • Spanish Society of Rheumatology. Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis. Reumatologia Clinica 2010;6:23-36.
    • (2010) Reumatologia Clinica , vol.6 , pp. 23-36
  • 33
    • 27244434053 scopus 로고    scopus 로고
    • Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR)
    • Pham T, Claudepierre P, Deprez X, Fautrel B, Goupille P, Hilliquin P, et al. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR). Joint Bone Spine 2005;72 Suppl 1:S1-58.
    • (2005) Joint Bone Spine , vol.72 , Issue.SUPPL. 1
    • Pham, T.1    Claudepierre, P.2    Deprez, X.3    Fautrel, B.4    Goupille, P.5    Hilliquin, P.6
  • 34
    • 34247338122 scopus 로고    scopus 로고
    • Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study
    • den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study. J Rheumatol 2007;34:689-95. (Pubitemid 46641372)
    • (2007) Journal of Rheumatology , vol.34 , Issue.4 , pp. 689-695
    • Den, B.A.A.1    Creemers, M.C.W.2    Fransen, J.3    De Jong, E.4    De Rooij, D.-J.R.5    Wymenga, A.6    De Waal-Malefijt, M.7    Van Den, H.F.H.J.8
  • 35
    • 33645904180 scopus 로고    scopus 로고
    • Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis
    • Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 2006;55:333-7.
    • (2006) Arthritis Rheum , vol.55 , pp. 333-337
    • Giles, J.T.1    Bartlett, S.J.2    Gelber, A.C.3    Nanda, S.4    Fontaine, K.5    Ruffing, V.6
  • 36
    • 3342881856 scopus 로고    scopus 로고
    • Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy
    • Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 2004;25:331-5. (Pubitemid 39096154)
    • (2004) Foot and Ankle International , vol.25 , Issue.5 , pp. 331-335
    • Bibbo, C.1    Goldberg, J.W.2
  • 37
    • 0038076340 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection
    • Long R, Gardam M. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. CMAJ 2003;168:1153-6. (Pubitemid 36543228)
    • (2003) Canadian Medical Association Journal , vol.168 , Issue.9 , pp. 1153-1156
    • Long, R.1    Gardam, M.2
  • 40
    • 62549155817 scopus 로고    scopus 로고
    • Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
    • Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum 2009;61:300-4.
    • (2009) Arthritis Rheum , vol.61 , pp. 300-304
    • Brassard, P.1    Lowe, A.M.2    Bernatsky, S.3    Kezouh, A.4    Suissa, S.5
  • 42
    • 77949477575 scopus 로고    scopus 로고
    • Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)
    • Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 2010;69:522-8.
    • (2010) Ann Rheum Dis , vol.69 , pp. 522-528
    • Dixon, W.G.1    Hyrich, K.L.2    Watson, K.D.3    Lunt, M.4    Galloway, J.5    Ustianowski, A.6
  • 43
    • 34250656516 scopus 로고    scopus 로고
    • Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
    • DOI 10.1002/art.22768
    • Gomez-Reino JJ, Carmona L, Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007;57:756-61. (Pubitemid 46932080)
    • (2007) Arthritis Care and Research , vol.57 , Issue.5 , pp. 756-761
    • Gomez-Reino, J.J.1    Carmona, L.2    Descalzo, M.A.3
  • 44
    • 0041653315 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors
    • may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report.
    • Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
    • (2003) Arthritis Rheum , vol.48 , pp. 2122-2127
    • Gomez-Reino, J.J.1    Carmona, L.2    Valverde, V.R.3    Mola, E.M.4    Montero, M.D.5
  • 45
    • 34247332718 scopus 로고    scopus 로고
    • Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): Effects of RA itself and of tumor necrosis factor blockers
    • Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): Effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34:706-11.
    • (2007) J Rheumatol , vol.34 , pp. 706-711
    • Seong, S.S.1    Choi, C.B.2    Woo, J.H.3    Bae, K.W.4    Joung, C.L.5    Uhm, W.S.6
  • 46
    • 67650096563 scopus 로고    scopus 로고
    • Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
    • Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 2009;60:1884-94.
    • (2009) Arthritis Rheum , vol.60 , pp. 1884-1894
    • Tubach, F.1    Salmon, D.2    Ravaud, P.3    Allanore, Y.4    Goupille, P.5    Breban, M.6
  • 47
    • 1042290327 scopus 로고    scopus 로고
    • Tuberculosis Infection in Patients with Rheumatoid Arthritis and the Effect of Infliximab Therapy
    • DOI 10.1002/art.20009
    • Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9. (Pubitemid 38198820)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.2 , pp. 372-379
    • Wolfe, F.1    Michaud, K.2    Anderson, J.3    Urbansky, K.4
  • 50
    • 0003573158 scopus 로고    scopus 로고
    • Ottawa: Public Health Agency of Canada; [Internet.Accessed April 2, 2012.] Available from
    • Public Health Agency of Canada. Canadian Tuberculosis Standards 2007. Ottawa: Public Health Agency of Canada; 2007. [Internet.Accessed April 2, 2012.] Available from: http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbstand07-eng.php
    • (2007) Canadian Tuberculosis Standards 2007
  • 51
    • 79958839671 scopus 로고    scopus 로고
    • Interferon-gamma release assays for diagnosis of latent tuberculosis infection: Evidence in immune-mediated inflammatory disorders
    • Smith R, Cattamanchi A, Steingart KR, Denkinger C, Dheda K, Winthrop KL, et al. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: Evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol 2011;23:377-84.
    • (2011) Curr Opin Rheumatol , vol.23 , pp. 377-384
    • Smith, R.1    Cattamanchi, A.2    Steingart, K.R.3    Denkinger, C.4    Dheda, K.5    Winthrop, K.L.6
  • 53
    • 33747044702 scopus 로고    scopus 로고
    • First Latin American position paper on the pharmacological treatment of rheumatoid arthritis
    • DOI 10.1093/rheumatology/kei500
    • Cardiel MH. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology 2006;45 Suppl:ii7-ii22. (Pubitemid 44445097)
    • (2006) Rheumatology , vol.45 , Issue.SUPPL. 2
    • Cardiel, M.H.1
  • 55
    • 75749141648 scopus 로고    scopus 로고
    • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
    • Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010;69 Suppl 1:i2-29.
    • (2010) Ann Rheum Dis , vol.69 , Issue.SUPPL. 1
    • Furst, D.E.1    Keystone, E.C.2    Fleischmann, R.3    Mease, P.4    Breedveld, F.C.5    Smolen, J.S.6
  • 56
    • 84873073482 scopus 로고    scopus 로고
    • Victoria, BC: British Columbia Ministry of Health; 2006. [Internet. Accessed April 2, 2012.] Available from
    • Guidelines and Protocols Advisory Committee. Rheumatoid arthritis: diagnosis and management; 2006. Victoria, BC: British Columbia Ministry of Health; 2006. [Internet. Accessed April 2, 2012.] Available from: http://www.bcguidelines.ca/guideline-ra.html
    • (2006) Rheumatoid Arthritis: Diagnosis and Management
  • 57
    • 67650930350 scopus 로고    scopus 로고
    • Management of patients with rheumatoid arthritis in Latin America: A consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide
    • Massardo L, Suarez-Almazor ME, Cardiel MH, Nava A, Levy RA, Laurindo I, et al. Management of patients with rheumatoid arthritis in Latin America: A consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide. J Clin Rheumatol 2009;15:203-10.
    • (2009) J Clin Rheumatol , vol.15 , pp. 203-210
    • Massardo, L.1    Suarez-Almazor, M.E.2    Cardiel, M.H.3    Nava, A.4    Levy, R.A.5    Laurindo, I.6
  • 58
    • 84992229908 scopus 로고    scopus 로고
    • Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis
    • Misra R, Sharma BL, Gupta R, Pandya S, Agarwal S, Agarwal P, et al. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J Rheumatol 2008;3 Suppl:S1-S16.
    • (2008) Indian J Rheumatol , vol.3 , Issue.SUPPL.
    • Misra, R.1    Sharma, B.L.2    Gupta, R.3    Pandya, S.4    Agarwal, S.5    Agarwal, P.6
  • 61
    • 77953696525 scopus 로고    scopus 로고
    • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
    • Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
    • (2010) Ann Rheum Dis , vol.69 , pp. 964-975
    • Smolen, J.S.1    Landewe, R.2    Breedveld, F.C.3    Dougados, M.4    Emery, P.5    Gaujoux-Viala, C.6
  • 62
    • 25444517037 scopus 로고    scopus 로고
    • BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment
    • British Thoracic Society Standards of Care Committee
    • British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005;60:800-5.
    • (2005) Thorax , vol.60 , pp. 800-805
  • 63
    • 77953694972 scopus 로고    scopus 로고
    • Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA
    • Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010;69:976-86.
    • (2010) Ann Rheum Dis , vol.69 , pp. 976-986
    • Nam, J.L.1    Winthrop, K.L.2    Van Vollenhoven, R.F.3    Pavelka, K.4    Valesini, G.5    Hensor, E.M.6
  • 64
    • 77953994043 scopus 로고    scopus 로고
    • Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010
    • Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
    • (2010) MMWR Recomm Rep , vol.59 , pp. 1-25
    • Mazurek, G.H.1    Jereb, J.2    Vernon, A.3    LoBue, P.4    Goldberg, S.5    Castro, K.6
  • 65
    • 72049104198 scopus 로고    scopus 로고
    • 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: A meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity
    • Ziakas PD, Mylonakis E. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: A meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Clin Infect Dis 2009;49:1883-9.
    • (2009) Clin Infect Dis , vol.49 , pp. 1883-1889
    • Ziakas, P.D.1    Mylonakis, E.2
  • 67
    • 79953161956 scopus 로고    scopus 로고
    • Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
    • van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011;10:341-52.
    • (2011) Autoimmun Rev , vol.10 , pp. 341-352
    • Van Assen, S.1    Elkayam, O.2    Agmon-Levin, N.3    Cervera, R.4    Doran, M.F.5    Dougados, M.6
  • 68
    • 29844450347 scopus 로고    scopus 로고
    • Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
    • DOI 10.1093/rheumatology/kei193
    • Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 2006;45:106-11. (Pubitemid 43033885)
    • (2006) Rheumatology , vol.45 , Issue.1 , pp. 106-111
    • Kapetanovic, M.C.1    Saxne, T.2    Sjoholm, A.3    Truedsson, L.4    Jonsson, G.5    Geborek, P.6
  • 69
    • 79952459799 scopus 로고    scopus 로고
    • General recommendations on immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention.
    • Centers for Disease Control and Prevention. General recommendations on immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-64.
    • (2011) MMWR Recomm Rep , vol.60 , pp. 1-64
  • 70
    • 0003859836 scopus 로고    scopus 로고
    • National Advisory Committee on Immunization 7th ed. Ottawa: Public Health Agency of Canada; Available from
    • National Advisory Committee on Immunization. Canadian immunization guide. 7th ed. Ottawa: Public Health Agency of Canada; 2006. Available from: http://www.phac-aspc.gc.ca/publicat/cig-gci/
    • (2006) Canadian Immunization Guide
  • 71
    • 79951553465 scopus 로고    scopus 로고
    • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
    • van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
    • (2011) Ann Rheum Dis , vol.70 , pp. 414-422
    • Van Assen, S.1    Agmon-Levin, N.2    Elkayam, O.3    Cervera, R.4    Doran, M.F.5    Dougados, M.6
  • 73
    • 33845620209 scopus 로고    scopus 로고
    • Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)
    • DOI 10.1080/17402520600800820, PII T37L065K5M402741
    • Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 2006;13:373-5. (Pubitemid 44950054)
    • (2006) Clinical and Developmental Immunology , vol.13 , Issue.2-4 , pp. 373-375
    • Stojanovich, L.1
  • 74
    • 0037102949 scopus 로고    scopus 로고
    • Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations
    • DOI 10.1086/341403
    • Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002;35:370-7. (Pubitemid 34852565)
    • (2002) Clinical Infectious Diseases , vol.35 , Issue.4 , pp. 370-377
    • Hak, E.1    Nordin, J.2    Wei, F.3    Mullooly, J.4    Poblete, S.5    Strikas, R.6    Nichol, K.L.7
  • 75
    • 0032517071 scopus 로고    scopus 로고
    • Benefits of influenza vaccination for low-, intermediate-, and high- risk senior citizens
    • DOI 10.1001/archinte.158.16.1769
    • Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76. (Pubitemid 28421420)
    • (1998) Archives of Internal Medicine , vol.158 , Issue.16 , pp. 1769-1776
    • Nichol, K.L.1    Wuorenma, J.2    Von Sternberg, T.3
  • 76
    • 84860829597 scopus 로고    scopus 로고
    • National Advisory Committee on Immunization Ottawa: Public Health Agency of Canada; [Internet. Accessed April 2, 2012.] Available from
    • National Advisory Committee on Immunization. Statement on human papilloma virus vaccine 2007. Ottawa: Public Health Agency of Canada; 2007. [Internet. Accessed April 2, 2012.] Available from: http://www.phac-aspc.gc.ca/publicat/ ccdr-rmtc/07vol33/acs-02/index-eng.php
    • (2007) Statement on Human Papilloma Virus Vaccine 2007
  • 78
    • 34047190402 scopus 로고    scopus 로고
    • Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients
    • DOI 10.1093/rheumatology/kel366
    • Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology 2007;46:608-11. (Pubitemid 46523304)
    • (2007) Rheumatology , vol.46 , Issue.4 , pp. 608-611
    • Kapetanovic, M.C.1    Saxne, T.2    Nilsson, J.-A.3    Geborek, P.4
  • 79
    • 0037079861 scopus 로고    scopus 로고
    • Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus
    • DOI 10.1086/338043
    • Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53. (Pubitemid 34028344)
    • (2002) Clinical Infectious Diseases , vol.34 , Issue.2 , pp. 147-153
    • Elkayam, O.1    Paran, D.2    Caspi, D.3    Litinsky, I.4    Yaron, M.5    Charboneau, D.6    Rubins, J.B.7
  • 80
    • 1442299282 scopus 로고    scopus 로고
    • The Effect of Tumor Necrosis Factor Blockade on the Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
    • DOI 10.1053/j.semarthrit.2003.10.003
    • Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8. (Pubitemid 38280827)
    • (2004) Seminars in Arthritis and Rheumatism , vol.33 , Issue.4 , pp. 283-288
    • Elkayam, O.1    Caspi, D.2    Reitblatt, T.3    Charboneau, D.4    Rubins, J.B.5
  • 81
    • 34248643414 scopus 로고    scopus 로고
    • Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone
    • Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 2007;34:952-7. (Pubitemid 46774837)
    • (2007) Journal of Rheumatology , vol.34 , Issue.5 , pp. 952-957
    • Visvanathan, S.1    Keenan, G.F.2    Baker, D.G.3    Levinson, A.I.4    Wagner, C.L.5
  • 83
    • 74849103999 scopus 로고    scopus 로고
    • Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
    • van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 2010;62:75-81.
    • (2010) Arthritis Rheum , vol.62 , pp. 75-81
    • Van Assen, S.1    Holvast, A.2    Benne, C.A.3    Posthumus, M.D.4    Van Leeuwen, M.A.5    Voskuyl, A.E.6
  • 84
    • 74849096560 scopus 로고    scopus 로고
    • Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
    • Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial. Arthritis Rheum 2010;62:64-74.
    • (2010) Arthritis Rheum , vol.62 , pp. 64-74
    • Bingham III, C.O.1    Looney, R.J.2    Deodhar, A.3    Halsey, N.4    Greenwald, M.5    Codding, C.6
  • 85
    • 44049085950 scopus 로고    scopus 로고
    • A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
    • Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:R45.
    • (2008) Arthritis Res Ther , vol.10
    • Smitten, A.L.1    Simon, T.A.2    Hochberg, M.C.3    Suissa, S.4
  • 86
    • 41649100103 scopus 로고    scopus 로고
    • Malignancy and biologic therapy in rheumatoid arthritis
    • DOI 10.1097/BOR.0b013e3282f7c706, PII 0000228120080500000018
    • Askling J, Bongartz T. Malignancy and biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol 2008;20:334-9. (Pubitemid 351483325)
    • (2008) Current Opinion in Rheumatology , vol.20 , Issue.3 , pp. 334-339
    • Askling, J.1    Bongartz, T.2
  • 87
    • 33644892763 scopus 로고    scopus 로고
    • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
    • Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
    • (2006) Arthritis Rheum , vol.54 , pp. 692-701
    • Baecklund, E.1    Iliadou, A.2    Askling, J.3    Ekbom, A.4    Backlin, C.5    Granath, F.6
  • 88
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • DOI 10.1001/jama.295.19.2275
    • Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85. (Pubitemid 43736578)
    • (2006) Journal of the American Medical Association , vol.295 , Issue.19 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 89
    • 67549122368 scopus 로고    scopus 로고
    • Etanercept therapy in rheumatoid arthritis and the risk of malignancies: A systematic review and individual patient data meta-analysis of randomised controlled trials
    • Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: A systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis 2009;68:1177-83.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1177-1183
    • Bongartz, T.1    Warren, F.C.2    Mines, D.3    Matteson, E.L.4    Abrams, K.R.5    Sutton, A.J.6
  • 90
    • 78751685797 scopus 로고    scopus 로고
    • Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: Meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
    • Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: Meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 2011;20:119-30.
    • (2011) Pharmacoepidemiol Drug Saf , vol.20 , pp. 119-130
    • Askling, J.1    Fahrbach, K.2    Nordstrom, B.3    Ross, S.4    Schmid, C.H.5    Symmons, D.6
  • 91
    • 80053565309 scopus 로고    scopus 로고
    • Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis
    • Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis. Ann Rheum Dis 2011;70:1895-904.
    • (2011) Ann Rheum Dis , vol.70 , pp. 1895-1904
    • Mariette, X.1    Matucci-Cerinic, M.2    Pavelka, K.3    Taylor, P.4    Van Vollenhoven, R.5    Heatley, R.6
  • 92
    • 77953103015 scopus 로고    scopus 로고
    • Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register
    • Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register. Arthritis Care Res 2010;62:755-63.
    • (2010) Arthritis Care Res , vol.62 , pp. 755-763
    • Dixon, W.G.1    Watson, K.D.2    Lunt, M.3    Mercer, L.K.4    Hyrich, K.L.5    Symmons, D.P.6
  • 93
    • 77955479672 scopus 로고    scopus 로고
    • Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
    • Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, et al. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther 2010;12:R5.
    • (2010) Arthritis Res Ther , vol.12
    • Strangfeld, A.1    Hierse, F.2    Rau, R.3    Burmester, G.R.4    Krummel-Lorenz, B.5    Demary, W.6
  • 95
    • 72249096209 scopus 로고    scopus 로고
    • Malignancies in the rheumatoid arthritis abatacept clinical development programme: An epidemiological assessment
    • Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, et al. Malignancies in the rheumatoid arthritis abatacept clinical development programme: An epidemiological assessment. Ann Rheum Dis 2009;68:1819-26.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1819-1826
    • Simon, T.A.1    Smitten, A.L.2    Franklin, J.3    Askling, J.4    Lacaille, D.5    Wolfe, F.6
  • 96
    • 77953108807 scopus 로고    scopus 로고
    • Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis
    • Hudson M, Suissa S. Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis. Arthritis Care Res 2010;62:805-10.
    • (2010) Arthritis Care Res , vol.62 , pp. 805-810
    • Hudson, M.1    Suissa, S.2
  • 97
    • 57349139451 scopus 로고    scopus 로고
    • Assessing the safety of new arthritis drugs: Are we there yet?
    • Suissa S. Assessing the safety of new arthritis drugs: Are we there yet? J Rheumatol 2008;35:2295-7.
    • (2008) J Rheumatol , vol.35 , pp. 2295-2297
    • Suissa, S.1
  • 99
    • 40449106365 scopus 로고    scopus 로고
    • Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis
    • DOI 10.1001/archinternmed.2007.107
    • Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med 2008;168:378-81. (Pubitemid 351347129)
    • (2008) Archives of Internal Medicine , vol.168 , Issue.4 , pp. 378-381
    • Bernatsky, S.1    Clarke, A.E.2    Suissa, S.3
  • 101
    • 44349093644 scopus 로고    scopus 로고
    • Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population
    • DOI 10.1016/j.semarthrit.2007.08.006, PII S0049017207001424
    • Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L, et al. Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 2008;37:388-97. (Pubitemid 351734521)
    • (2008) Seminars in Arthritis and Rheumatism , vol.37 , Issue.6 , pp. 388-397
    • Abasolo, L.1    Judez, E.2    Descalzo, M.A.3    Gonzalez-Alvaro, I.4    Jover, J.A.5    Carmona, L.6
  • 102
    • 41849140880 scopus 로고    scopus 로고
    • Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002
    • DOI 10.1136/ard.2007.075986
    • Herrinton LJ, Liu L, Shoor S, Mines D. Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Ann Rheum Dis 2008;67:574-5. (Pubitemid 351498446)
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.4 , pp. 574-575
    • Herrinton, L.J.1    Liu, L.2    Shoor, S.3    Mines, D.4
  • 103
    • 2642554059 scopus 로고    scopus 로고
    • Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
    • DOI 10.1002/art.20311
    • Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51. (Pubitemid 38725085)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.6 , pp. 1740-1751
    • Wolfe, F.1    Michaud, K.2
  • 104
    • 66149084485 scopus 로고    scopus 로고
    • Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register
    • Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009;68:648-53.
    • (2009) Ann Rheum Dis , vol.68 , pp. 648-653
    • Askling, J.1    Baecklund, E.2    Granath, F.3    Geborek, P.4    Fored, M.5    Backlin, C.6
  • 106
    • 34248547187 scopus 로고    scopus 로고
    • The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
    • DOI 10.1002/art.22579
    • Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007;56:1433-9. (Pubitemid 46764070)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.5 , pp. 1433-1439
    • Wolfe, F.1    Michaud, K.2
  • 107
    • 17644374819 scopus 로고    scopus 로고
    • Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
    • DOI 10.1136/ard.2004.030528
    • Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005;64:699-703. (Pubitemid 40559295)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.5 , pp. 699-703
    • Geborek, P.1    Bladstrom, A.2    Turesson, C.3    Gulfe, A.4    Petersson, I.F.5    Saxne, T.6    Olsson, H.7    Jacobsson, L.T.H.8
  • 109
    • 75849118366 scopus 로고    scopus 로고
    • Lymphoma in patients treated with anti-TNF: Results of the 3-year prospective French RATIO registry
    • Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, et al. Lymphoma in patients treated with anti-TNF: Results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010;69:400-8.
    • (2010) Ann Rheum Dis , vol.69 , pp. 400-408
    • Mariette, X.1    Tubach, F.2    Bagheri, H.3    Bardet, M.4    Berthelot, J.M.5    Gaudin, P.6
  • 110
  • 111
    • 34848893989 scopus 로고    scopus 로고
    • Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study
    • DOI 10.1002/art.22864
    • Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95. (Pubitemid 47502734)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.9 , pp. 2886-2895
    • Wolfe, F.1    Michaud, K.2
  • 112
    • 70350548170 scopus 로고    scopus 로고
    • Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment?
    • Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, et al. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment? Arthritis Rheum 2009;60:3180-9.
    • (2009) Arthritis Rheum , vol.60 , pp. 3180-3189
    • Askling, J.1    Van Vollenhoven, R.F.2    Granath, F.3    Raaschou, P.4    Fored, C.M.5    Baecklund, E.6
  • 113
    • 67149120677 scopus 로고    scopus 로고
    • Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
    • Burmester GR, Mease P, Dijkmans BAC, Gordon K, Lovell D, Panaccione R, et al. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis 2009;68:1863-9.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1863-1869
    • Burmester, G.R.1    Mease, P.2    Dijkmans, B.A.C.3    Gordon, K.4    Lovell, D.5    Panaccione, R.6
  • 115
    • 38649126529 scopus 로고    scopus 로고
    • Lung cancer after exposure to disease modifying anti-rheumatic drugs
    • DOI 10.1016/j.lungcan.2007.06.013, PII S0169500207003662
    • Bernatsky S, Clarke A, Suissa S. Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung Cancer 2008;59:266-9. (Pubitemid 351173401)
    • (2008) Lung Cancer , vol.59 , Issue.2 , pp. 266-269
    • Bernatsky, S.1    Clarke, A.2    Suissa, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.